MYGN - Myriad Genetics, Inc.
IEX Last Trade
28.32
0 0%
Share volume: 883,549
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$28.32
0.00
0.00%
Summary score
4%
Profitability
0%
Dept financing
9%
Liquidity
27%
Performance
1%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-4.38%
Return on assets
-2.62%
Return on sales
-21.22%
Return on invested capital
-4.72%
Total debt ratio
30.71%
Debt ratio change over timeo
-9.42%
Current Ratio
2.33%
Quick Ratio
2.18%
Cash Position Ratio
1.15%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.04%
Return on assets
-2.61%
Return on sales
-15.61%
Return on invested capital
-8.71%
Total debt ratio
35.46%
Debt ratio change over timeo
-6.43%
Current Ratio
1.65%
Quick Ratio
1.52%
Cash Position Ratio
0.64%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-3.42%
Return on assets
-2.51%
Return on sales
-13.8%
Return on invested capital
-3.86%
Total debt ratio
31.56%
Debt ratio change over time
-7.85%
Current Ratio
1.99%
Quick Ratio
1.82%
Cash Position Ratio
0.71%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-5.07%
Return on assets
-56.28%
Return on sales
324.12%
Return on invested capital
9.47%
Total debt ratio
-942.49%
Debt ratio change over time
-9.42%
Current Ratio
-65.5%
Quick Ratio
-62.06%
Cash Position Ratio
-33.47%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MYGN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -4.38% | 13.79% | 34.47% | 7.43% |
| Return on assets | -2.62% | 2.76% | 3.15% | 5.62% |
| Return on sales | -21.22% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -4.72% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 30.71% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -9.42% | 308.97% | -6.99% | 1.18% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 1.65% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.52% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.64% | 0.36% | 1.28% | 2.93% |
| Liquididy | 42% | 14% | 33% | 75% |
| Short-term ratios | MYGN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.04% | 13.77% | 13.25% | 3.8% |
| Return on assets | -2.61% | 2.43% | 1.89% | 3.09% |
| Return on sales | -15.61% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -8.71% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 35.46% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -6.43% | 46.38% | -72.08% | 1.51% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 1.65% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.52% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.64% | 0.36% | 1.28% | 2.93% |
| Liquididy | 21% | 12% | 31% | 75% |